NEW YORK, June 4 – Isis Pharmaceuticals has appointed Richard Brown to lead its GeneTrove functional genomics division, the company said Monday.

Brown, formerly president of Irori, the technology and instrumentation division of Discovery Partners International, a combinatorial chemistry company, will oversee all scientific and business operations of the division, including the launch of the GeneTrove Gene Function Database later this year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.